Press Releases
Illumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies
Illumina Ventures Leads €16M Series A Investment in Digital PCR Firm Stilla Technologies November 2018, Article on Genomeweb.com Get the PDF file Stilla Technologies announced today that it has completed a €16 [...]
Paris-based Stilla Technologies has raised €16M in a Series A round to sell and develop a high-precision PCR system for DNA quantification
Paris-based Stilla Technologies has raised €16M in a Series A round November 2018, Article on Labiotech.eu Get the PDF file Paris-based Stilla Technologies has raised €16M in a Series A round to [...]
Stilla Technologies completes €16 Million ($18 Million) Series A
November 20th, 2018 Stilla Technologies completes €16 Million Series A Illumina Ventures led the financing round Objective: financing to commercialize its novel digital PCR system and develop clinical applications. Paris, November 20th, 2018. [...]
Stilla’s webinar in collaboration with Genomeweb and University Hospital of Dijon on Tuesday 25th of September 2018
September the 25th 2018, Implementation of Digital PCR in a Diagnostic Lab: Evaluation of Minimal Residual Disease by Dr Benjamin Tournier, University Hospital of Dijon 8 AM PDT | 11 AM EDT | 4PM [...]
Stilla’s webinar in collaboration with Nature and ICR London on Tuesday 12th of June 2018
June the 12th 2018, Multicolour Digital PCR for ctDNA detection in breast cancer,by Dr Isaac Garcia-Murillas, ICR London8 AM PDT | 11 AM EDT | 4PM BST | 5PM CEST Speaker’s Bio Dr Isaac Garcia-Murillas [...]
Stilla Technologies: Official Supplier of APHP Paris Hospitals
March 26, 2018 Stilla Technologies: Official Supplier of APHP Paris Hospitals Stilla Technologies has been awarded the public tender for digital PCR instrumentation by the APHP (Assistance Publique des Hôpitaux Paris). Stilla is [...]